Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bosentan on Pulmonary Artery Remodelling in PAH
NCT00595049Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started May 2006; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00595049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595049.